Acacia, CombiMatrix, University of Colorado, Almac, Lumera, Harvard Medical School, Qiagen, Eppendorf, Duke, Affy, Imgenex, Epitome, Bristol-Myers Squibb, GenTel | GenomeWeb

Acacia to Spin Out CombiMatrix as Independent Company;
University of Colorado First to Join CombiCore Program

Acacia Research said this week that its board of directors has approved a plan for its CombiMatrix microarray subsidiary to become an independent public company.

Acacia said it expects the transaction to close in the second quarter of 2006, subject to receiving a "satisfactory tax opinion from legal counsel" and other conditions.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.